SCHEMBL28040157

SCHEMBL28040157

O=C(O)C1CNC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27272784 1.00
SCHEMBL11071786 0.81 CYP2C19 (0.36)
SCHEMBL23002187 0.80 IDUA (0.31)
SCHEMBL23002172 0.78 TLR4 (0.32)
SCHEMBL23002181 0.78 GABRR1 (0.33)
SCHEMBL27699874 0.77
SCHEMBL9617646 0.77
SCHEMBL5324376 0.77
SCHEMBL24108598 0.75
SCHEMBL149411 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109476653-A The heteroaromatic regulator of retinoids related orphan receptor y 利奥制药有限公司 2019-03-15 CN disclosed
CN-106029064-B Therapeutic compounds and compositions 艾克赛特赫拉制药有限责任公司 2018-08-14 CN disclosed
CN-105189512-A Pyrrolopyrimindine CDK9 kinase inhibitors ABBVIE INC 2015-12-23 CN disclosed